Literature DB >> 7930744

Immunopathogenesis of human inflammatory arthritis: lessons from Lyme and reactive arthritis.

R Lahesmaa1, M C Shanafelt, L Steinman, G Peltz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930744     DOI: 10.1093/infdis/170.4.978

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

Review 1.  Two forms of reactive arthritis?

Authors:  P Toivanen; A Toivanen
Journal:  Ann Rheum Dis       Date:  1999-12       Impact factor: 19.103

Review 2.  Host-pathogen interactions in the immunopathogenesis of Lyme disease.

Authors:  L T Hu; M S Klempner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

3.  Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14.

Authors:  G H Giambartolomei; V A Dennis; B L Lasater; M T Philipp
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages.

Authors:  M L Linn; L Mateo; J Gardner; A Suhrbier
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Human gamma delta T-cell recognition of Yersinia enterocolitica.

Authors:  J L Young; J C Goodall; H Beacock-Sharp; J S Gaston
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

6.  Cytokines in Mycoplasma hyorhinis-induced arthritis in pigs bred selectively for high and low immune responses.

Authors:  N R Jayagopala Reddy; B N Wilkie; P Borgs; B A Mallard
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis.

Authors:  J Oksi; J Savolainen; J Pène; J Bòusquet; P Laippala; M K Viljanen
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.